Sun-damaged Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2016-09-05
Clinical Trial Update: Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma [Phase 2]
Phase 2 trial of dasatinib in acral lentiginous, mucosal, or chronic sun-damaged melanoma was terminated, with results posted.